These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10206376)

  • 1. Drugs for ventricular arrhythmias in the era of the implantable cardioverter defibrillator.
    Peters NS
    Eur Heart J; 1999 Mar; 20(5):321-3. PubMed ID: 10206376
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs].
    Haverkamp W; Borggrefe M; Block M; Böcker D; Breithardt G
    Z Kardiol; 1996; 85 Suppl 6():97-106. PubMed ID: 9064989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irregular ventricular tachycardia underdetected by implantable cardioverter defibrillator device.
    Manolis AG; Kourouklis S; Chatzis D; Kouvelas K; Kyriakides Z
    Cardiol J; 2008; 15(3):281-3. PubMed ID: 18651422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of long-standing implantable cardioverter-defibrillator patients with and without appropriate therapy for ventricular arrhythmias: impact of a widening QRS.
    Dizon J; Chen K; Dizon S; Biviano A; Whang W; Ehlert F; Vazquez J; Nazif T; Garan H
    Europace; 2011 Jan; 13(1):77-81. PubMed ID: 21149513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone versus implantable cardioverter defibrillator for asymptomatic nonsustained ventricular tachycardia in nonischemic dilated cardiomyopathy.
    Cawley PJ; Al-Khatib SM
    Am Heart J; 2004 May; 147(5):790-1. PubMed ID: 15131532
    [No Abstract]   [Full Text] [Related]  

  • 6. Sudden cardiac death: who needs an implantable cardioverter-defibrillator and who needs antiarrhythmic drugs?
    Ferrari R; Cinca J; Marber M
    Eur Heart J; 1999 Mar; 20(6):397-8. PubMed ID: 10213339
    [No Abstract]   [Full Text] [Related]  

  • 7. Implantable cardioverter defibrillator therapy for patients with chronic Chagas' disease: a randomized trial may not be necessary in high-risk patients.
    Bestetti R; Cardinalli-Neto A
    Europace; 2009 Apr; 11(4):537. PubMed ID: 19279026
    [No Abstract]   [Full Text] [Related]  

  • 8. Follow-up defibrillator testing for antiarrhythmic drugs: probability and uncertainty.
    Wood MA; Ellenbogen KA
    Circulation; 2006 Jul; 114(2):98-100. PubMed ID: 16831995
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of appropriate cardioverter-defibrillator shocks in 1038 consecutive patients with implantable cardioverter-defibrillators.
    Kruger A; Aronow WS; Lai H; Desai H; Singla A; Frishman WH; Cohen M; Sorbera C
    Am J Ther; 2009; 16(4):323-5. PubMed ID: 19617719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
    Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
    N Engl J Med; 1997 Nov; 337(22):1576-83. PubMed ID: 9411221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
    Della Bella P
    Ital Heart J Suppl; 2000 Aug; 1(8):1070-1. PubMed ID: 10993020
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
    Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and management of ventricular tachycardia.
    Naik N; Talwar KK
    J Indian Med Assoc; 2003 Feb; 101(2):62-5, 95. PubMed ID: 12841484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empiric antiarrhythmic drug therapy in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: pragmatism or anachronism?
    Mitchell LB
    J Am Coll Cardiol; 2009 Aug; 54(7):616-7. PubMed ID: 19660691
    [No Abstract]   [Full Text] [Related]  

  • 16. Quinidine ceases electrical storm in an ablated patient with an implantable cardioverter-defibrillator: an old lady in the modern era.
    Georgiadou P; Iliodromitis EK; Theodorakis GN; Kremastinos DT
    Int J Cardiol; 2006 Oct; 113(1):129-31. PubMed ID: 16318889
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
    Fuchs T; Groysman R; Meilichov I
    Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardiac defibrillators.
    Spivack C
    N Engl J Med; 2002 Aug; 347(5):365-7; author reply 365-7. PubMed ID: 12154817
    [No Abstract]   [Full Text] [Related]  

  • 19. [Implantable cardioverter defibrillator does not eliminate need for antiarrhythmic drugs in secondary prevention of life threatening ventricular arrhythmias. Results of OPTIC trial].
    Iavelov IS
    Kardiologiia; 2006; 46(3):74-5. PubMed ID: 16710262
    [No Abstract]   [Full Text] [Related]  

  • 20. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
    Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ
    Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.